Newton Charles W.
Transaction: 06/05/2026
BUY
Change
+30,000
Price
Not reported
Filing
06/09/2026
Type
BUY
Coherus Oncology, Inc.
CHRS • Biotechnology
$1.42
▲ +0.05 (+3.65%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$219.84M
Growth
-4.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.66Healthy liquidity · 1.46Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:38 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.42
Change3.65%
Shares Out154.82M
Market Cap$219.84M
Enterprise Value$151.78M
52W Range0.81 - 2.62
Beta0.98
P/E-1.68
P/S4.32
P/B3.61
P/FCF-0.90
EV/Sales2.98
Price$1.42
Change3.65%
Shares Out154.82M
Market Cap$219.84M
Enterprise Value$151.78M
52W Range0.81 - 2.62
Beta0.98
P/E-1.68
P/S4.32
P/B3.61
P/FCF-0.90
EV/Sales2.98
EV/EBITDA-0.99
EV/FCF-0.62
Earnings Yield-59.57%
FCF Yield-110.95%
Dividend Yield0.00%
Gross Margin57.94%
Oper. Margin-4.26%
Profit Margin-4.04%
Debt/Eq0.66
Current Ratio1.46
Quick Ratio1.43
Revenue 5Y-4.89%
Target$6.02
Target Upside323.94%
Target Median$6.00
Target Range1.05 - 11.00
Volume70.25K
Avg Volume1.05M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
75/100
Why this score▼
Manageable debt level · 0.66Healthy liquidity · 1.46Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 17 analyst votes · 2026-09-05
91/100
Bullish
Bullish
14
Hold
3
Bearish
0
Price Target
2026-08-07
Low
$1.05
Mean
$6.02
Median
$6.00
High
$11.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Newton Charles W.
Transaction: 06/05/2026
BUY
Change
+60,000
Price
$1.45
Filing
06/09/2026
Type
BUY
Wahlstrom Mats
Transaction: 06/05/2026
BUY
Change
+30,000
Price
Not reported
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Newton Charles W. | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Newton Charles W. | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Wahlstrom Mats | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Wahlstrom Mats | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| O'Donnell-Tormey Jill | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| O'Donnell-Tormey Jill | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Ryan Michael Lee | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Ryan Michael Lee | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Newcomer Lee Nisley | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Newcomer Lee Nisley | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Karachun Rita A | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Karachun Rita A | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Satvat Ali J. | BUY | +30,000 | Not reported | 06/05/2026 | 06/09/2026 |
| Satvat Ali J. | BUY | +60,000 | $1.45 | 06/05/2026 | 06/09/2026 |
| Lanfear Dennis M | SELL | -402,500 | $15.94 | 05/29/2026 | 06/02/2026 |
| McMichael Bryan J | SELL | -25,000 | $9.87 | 05/29/2026 | 06/02/2026 |
| Lanfear Dennis M | BUY | +750,000 | $2.06 | 01/23/2026 | 01/26/2026 |
| Lanfear Dennis M | BUY | +375,000 | Not reported | 01/23/2026 | 01/26/2026 |
| McMichael Bryan J | BUY | +112,500 | Not reported | 01/22/2026 | 01/26/2026 |
| McMichael Bryan J | BUY | +225,000 | $1.59 | 01/22/2026 | 01/26/2026 |